A comparative pharmacodynamic study of ticagrelor versus clopidogrel and ticagrelor in patients undergoing primary percutaneous coronary intervention: the CAPITAL RELOAD study. by Benjamin Hibbert, Ronnen Maze, Ali Pourdjabbar, Trevor Simard, F Daniel Ramirez, Rohit Moudgil, Melissa Blondeau, Marino Labinaz, Alexander Dick, Christopher Glover, Michael Froeschl, Jean-François Marquis, Derek Y F So, Michel R Le May

Get full text

Impact of baseline beta-blocker use on inotrope response and clinical outcomes in cardiogenic shock: a subgroup analysis of the DOREMI trial by Pietro Di Santo, Rebecca Mathew, Richard G. Jung, Trevor Simard, Stephanie Skanes, Brennan Mao, F. Daniel Ramirez, Jeffrey A. Marbach, Omar Abdel-Razek, Pouya Motazedian, Simon Parlow, Kevin E. Boczar, Gianni D’Egidio, Steven Hawken, Jordan Bernick, George A. Wells, Alexander Dick, Derek Y. So, Christopher Glover, Juan J. Russo, Caroline McGuinty, Benjamin Hibbert, the CAPITAL DOREMI investigators

Get full text

De-escalation of P2Y12 Inhibitor Use After Percutaneous Coronary Intervention and Acute Coronary Syndromes by Quinton Barry, BMBS, FRCPC, Angel Fu, MD, FRCPC, Rene Boudreau, MD, FRCPC, Alyssa Chow, BSc, Cole Clifford, BSc, Trevor Simard, MD, FRCPC, Aun Yeong Chong, MBBS, FRCPC, Alexander Dick, MD, FRCPC, Michael Froeschl, MD, FRCPC, Christopher Glover, MD, FRCPC, Benjamin Hibbert, MD, FRCPC, Marino Labinaz, MD, FRCPC, Michel Le May, MD, FRCPC, FACC, Juan Russo, MD, FRCPC, Derek So, MD, FRCPC, FACC

Get full text